• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Infographic: Hybrid Closed-Loop Insulin Delivery Systems - Outcomes and Outlooks

Article

Hybrid closed-loop insulin delivery systems, also called an “artificial pancreas,” have attracted a great deal of attention since the FDA approved the first such device last September. These systems continuously monitor blood glucose levels and adjust insulin dosing accordingly, although they require some input from users around mealtimes.

Hybrid closed-loop insulin delivery systems, also called an “artificial pancreas,” have attracted a great deal of attention since the FDA approved the first such device last September. These systems continuously monitor blood glucose levels and adjust insulin dosing accordingly, although they require some input from users around mealtimes.

Supporters envision that these technologies could help more patients with diabetes optimally control their blood glucose, especially among younger populations that may find it more difficult to administer the right amount of insulin at the right time. At the 77th Scientific Sessions of the American Diabetes Association, a symposium discussed progress towards the artificial pancreas, inviting experts to discuss perspectives from the European and US viewpoints. For more on the take-aways from this symposium, see the infographic below.

Related Videos
Pregnant Patient | image credit: pressmaster - stock.adobe.com
Diana Isaacs, PharmD
Beau Raymond, MD
Robert Zimmerman, MD
Beau Raymond, MD
Dr Kevin Mallow, PharmD, BCPS, BC-ADM, CDCES
Ian Neeland, MD
Chase D. Hendrickson, MD, MPH
Steven Coca, MD, MS, Icahn School of Medicine, Mount Sinai
Matthew Crowley, MD, MHS, associate professor of medicine, Duke University School of Medicine.
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.